share_log

Stifel Maintains Buy on Sabra Health Care REIT, Raises Price Target to $16

Stifel Maintains Buy on Sabra Health Care REIT, Raises Price Target to $16

Stifel维持对Sabra Health Care REIT的买入,将目标股价提高至16美元
Benzinga ·  2023/11/07 10:10

Stifel analyst Stephen Manaker maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy and raises the price target from $14 to $16.

Stifel分析师斯蒂芬·马纳克维持Sabra Health Care REIT(纳斯达克股票代码:SBRA)的买入,并将目标股价从14美元上调至16美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发